The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer

Delphine Fessart1,2,3, Jacques Robert4, Cecile Hartog4

  • 1INSERM U1242, "Chemistry, Oncogenesis Stress Signaling", Université Rennes 1, Rennes, France. delphine.fessart@inserm.fr.

Insights

Anterior gradient proteins AGR2 and AGR3 are implicated in epithelial ovarian cancer (EOC). Understanding their role may lead to new diagnostic and therapeutic strategies for this lethal gynecologic malignancy.

Area of Science:

  • Gynecology
  • Oncology
  • Molecular Biology

Background:

  • Epithelial ovarian cancer (EOC) is a leading cause of cancer death in women globally.
  • Despite therapeutic advances, EOC remains highly lethal, necessitating novel treatment strategies.
  • Anterior gradient (AGR) proteins, AGR2 and AGR3, are related to protein disulfide isomerase (PDI) and are implicated in adenocarcinoma development.

Purpose of the Study:

  • To review the current understanding of AGR family proteins in EOC.
  • To explore the expression patterns of AGR2 and AGR3 in EOC.
  • To discuss the potential clinical utility of AGR2 and AGR3 in EOC management.

Main Methods:

  • Literature review of studies on AGR proteins and EOC.
  • Analysis of existing data on AGR2 and AGR3 expression in EOC tissues.
  • Synthesis of information regarding the functional roles of AGR2 and AGR3 in cancer.

Main Results:

  • AGR2 and AGR3 are expressed in EOC and may play a role in its pathogenesis.
  • Expression levels of AGR2 and AGR3 could correlate with EOC diagnosis and patient outcomes.
  • AGR proteins represent potential targets for novel EOC therapies.

Conclusions:

  • The AGR family, particularly AGR2 and AGR3, is relevant to epithelial ovarian cancer.
  • Further research into AGR proteins could uncover new diagnostic biomarkers and therapeutic targets for EOC.
  • Targeting AGR family proteins may offer new avenues for managing EOC patients.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K